comparemela.com

Latest Breaking News On - Tungsten advisors - Page 1 : comparemela.com

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™ - Blue Water Biotech (NASDAQ:BWV)

CINCINNATI, Dec. 18, 2023 (GLOBE NEWSWIRE) Blue Water Biotech, Inc. (NASDAQ:BWV) ("BWB" or the "Company") today announced the acquisition of Proteomedix AG, a private, commercial-stage diagnostics oncology

Proteomedix Agrees to Issue Labcorp Exclusive License for Proclarix Blood Test to Detect Prostate Cancer

Labcorp Plans to Develop and Commercialize the Innovative Prostate Cancer Liquid Biopsy Test in the U.S. Proteomedix, a Swiss diagnostics company committed to advancing prostate cancer care, announced

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.